
    
      The purpose of this study is to evaluate the efficacy and safety of LaxymigÂ® ER compared with
      placebo in prophylactic monotherapy treatment of migraine headache.

      Four weeks baseline, following with 12 weeks treatment phase. Subjects migraine are recorded
      by diary cards and re-evaluated by the investigator.

      Subject will have visit every 4-week (+/- 7 days).
    
  